Baird Downgrades Genpact to Neutral, Announces $38 Price Target
Portfolio Pulse from Benzinga Newsdesk
Baird analyst David Koning has downgraded Genpact (NYSE:G) from Outperform to Neutral and set a price target of $38. This reflects a more cautious stance on the company's stock.
December 15, 2023 | 11:01 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Genpact downgraded by Baird from Outperform to Neutral with a $38 price target, indicating a potential pause in upward momentum.
Downgrades by analysts can lead to a negative perception among investors, potentially causing a short-term decline in the stock price. The new price target of $38 may also suggest limited upside potential from the current trading level, influencing investor sentiment.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100